Loading stock data…
ARDT
$10.15+0.39 (+4.00%)
Market ClosedLast close May 1
Ardent Health, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Ardent Health, Inc. in the Healthcare sector is trading at $10.15. The stock is currently 34% below its 52-week high of $15.48, remaining 5.4% below its 200-day moving average. Technical signals show neutral RSI of 65 and bullish MACD crossover, explaining why ARDT maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Overbought levels (RSI 65) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$10.15
Potential Upside
75.4%
Whystock Fair Value$17.81
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, or...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.41B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
10.26
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-
Volume
Today's trading volume
690,253
Recent News
BrightSpring Health Services, Inc. (BTSG) Q1 Earnings and Revenues Beat Estimates
BrightSpring Health Services, Inc. (BTSG) delivered earnings and revenue surprises of +35.42% and +8.35%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Avantor, Inc. (AVTR) Q1 Earnings and Revenues Top Estimates
Avantor (AVTR) delivered earnings and revenue surprises of +5.85% and +2.11%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
How Ardent Health (ARDT) Narrative Is Shifting As Valuation Resets And Operations Steady
Ardent Health is back in focus after analysts trimmed their fair value estimate from $12.73 to $12.44, a small reset that still reflects largely unchanged assumptions on the core business. The shift comes alongside Street commentary that balances slightly lower targets with improving Q4 execution, steadier payer denials, solid patient volumes, and views that the current share price may look undemanding to some. Read on to see how to track these evolving signals and what they could mean for...
Is It Time To Reassess Ardent Health (ARDT) After A 23% One Year Share Price Fall
If you are wondering whether Ardent Health's current share price reflects its real worth, this breakdown will help you size up what you are actually paying for. The stock last closed at US$9.42, with returns of 4.4% over the past week, 0.3% over the past month, 9.0% year to date, and a 23.4% decline over the past year. Recent coverage around Ardent Health has focused on its position within the broader healthcare sector and how investors are weighing its prospects against peers. This context...
AUNA Climbs 21.5% YTD, Outperforms Industry: How to Play the Stock?
AUNA S.A. rallies as Peru delivers steady growth, Mexico shows turnaround signs, and improved liquidity and cash flow boost confidence in its outlook.